SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): April 27, 2004
DEPOMED, INC.
(Exact name of registrant as specified in its charter)
|
California |
|
001-13111 |
|
94-3229046 |
|
(State of Incorporation or Organization) |
|
(Commission File Number) |
|
(I.R.S. Employer Identification No.) |
|
|
|
|
|
|
|
1360 O’Brien Drive, Menlo Park, California |
|
94025 |
||
|
(Address of principal executive offices) |
|
(Zip Code) |
||
|
|
|
|
|
|
|
Registrant’s telephone no., including area code: (650) 462-5900 |
||||
|
|
|
|
|
|
|
NOT APPLICABLE |
||||
|
(Former name or former address, if changed since last report) |
||||
Item 5. Other Events.
On April 27, 2004, Depomed, Inc., a California corporation (“Depomed”), amended its License and Development Agreement, dated as of May 28, 2002, with Biovail Laboratories Incorporated (“Biovail”), a wholly-owned subsidiary of Biovail Corporation. The Amended License and Development Agreement, dated as of April 27, 2004, between Depomed and Biovail is attached hereto as Exhibit 10.1 and is incorporated herein by this reference.
Item 7. Financial Statements and Exhibits.
|
Exhibits. |
|
|
|
|
|
|
|
10.1 |
|
Amended License and Development Agreement, dated as of April 27, 2004, between Depomed, Inc. and Biovail Laboratories Incorporated.* |
* confidential treatment requested
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
DEPOMED, INC. |
|
|
|
|
|
|
|
|
|
|
|
/s/ John F. Hamilton |
|
|
|
John F. Hamilton |
|
|
|
Vice President - Finance and |
|
|
|
Chief Financial Officer |
|
|
|
||
|
Date: May 4, 2004 |
||
3
EXHIBIT INDEX
|
Exhibit |
|
|
|
|
|
|
|
10.1 |
|
Amended License and Development Agreement, dated as of April 27, 2004, between Depomed, Inc. and Biovail Laboratories Incorporated.* |
* confidential treatment requested
4